Natixis »

Aldeyra Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2023-03-31 $6.7M 675k 9.93
2022-12-31 $302k 44k 6.82

More positions owned by Natixis

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Energy Transfer Com Ut Ltd Ptn (ET)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Indl (XLI)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Amazon (AMZN)
UnitedHealth (UNH)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Scientific Games (LNW)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)

View all positions for Natixis

Top funds holding Aldeyra Therapeutics

Perceptive Advisors
Knoll Capital Management
Vanguard Group
Kennedy Capital Management
Dimensional Fund Advisors
Damian Sousa
Millennium Management
Thomas Stevens, CFA"
Bank of America Corporation
Two Sigma Advisers
Wells Fargo & Company
Deutsche Bank Aktiengesellschaft
D. E. Shaw & Co
Palo Alto Investors
Two Sigma Investments

View all funds holding Aldeyra Therapeutics